T3 · Product exporter position

Netherlands exports of Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions (HS 300212)

See where Netherlands stands in blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions: export scale, destination breadth, market position, growth, and reported trade history.

Explore this product View destinations

Exporter NLDHS6 300212Latest year 2024Rapid growth

Latest exports

$1.3BLatest observed lane total

Destination markets

119Reported active markets

Three-year growth

+17.9%Annualized change

Destination HHI

1,322Destination concentration

Weighted share

7.9%Reported market position

Exporter evidence

How strong is Netherlands in Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions?

Reported exporter totals and calculated indicators for HS 300212. Values retain their observed coverage period.

Exporter scale

Latest exports$1.3B

Current 2024 exports$1.3B

Three-year average$1.1B

Historical peak$2.2B

Market position

Active destinations119

Destination HHI1,322

Weighted share7.9%

Share change+1.5 pp

Competitiveness

Three-year growth+17.9%

Volatility1.2

Maximum drawdown81.3%

TrendRapid growth

Measure	Value	What it describes
Exporter	Netherlands	Country represented by this profile
Latest observed exports	$1.3B	Sum of latest observed destination-lane values
Current 2024 exports	$1.3B	Common-year comparison where reported
Three-year growth	+17.9%	Annualized change in exporter totals
Five-year growth	+16.7%	Annualized change in exporter totals
Leading destination	CHE	Destination with the largest observed export value
Leading destination share	29.9%	Share of observed exporter totals
Destination concentration	1,322	HHI across destination markets
Weighted share change	+1.5 pp	Value-weighted latest change in market share
Limited-history lanes	16.1%	Share of lanes with shorter history

Destination markets

Where does Netherlands sell blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions?

Leading destination observations ranked by reported export value, with market position and access context.

Destination	Latest exports	Market share	Growth	Access	Signal
Switzerland, Liechtenstein	$394.1M	7.1%	+211.1%	FTA reported	Accelerating
France	$171.5M	12%	+16.6%	FTA reported	Growing
Germany	$132.7M	1.8%	-3.9%	FTA reported	Stable
Ireland	$88.2M	8%	+8%	FTA reported	Accelerating
Poland	$76.0M	11.8%	+20.2%	FTA reported	Accelerating
Italy	$71.6M	4.9%	+11.6%	FTA reported	Accelerating

Destination

Switzerland, Liechtenstein

Latest exports: $394.1M
Market share: 7.1%
Growth: +211.1%
Access: FTA reported
Signal: Accelerating

Destination

France

Latest exports: $171.5M
Market share: 12%
Growth: +16.6%
Access: FTA reported
Signal: Growing

Destination

Germany

Latest exports: $132.7M
Market share: 1.8%
Growth: -3.9%
Access: FTA reported
Signal: Stable

Destination

Ireland

Latest exports: $88.2M
Market share: 8%
Growth: +8%
Access: FTA reported
Signal: Accelerating

Destination

Poland

Latest exports: $76.0M
Market share: 11.8%
Growth: +20.2%
Access: FTA reported
Signal: Accelerating

Destination

Italy

Latest exports: $71.6M
Market share: 4.9%
Growth: +11.6%
Access: FTA reported
Signal: Accelerating

Price intelligence

How does Netherlands's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Indonesia: $68.3M / ton.

Lowest reported price

Uzbekistan: $249.0 / ton.

Median price

$387.7K / ton across reported markets.

Export trend

Reported export history

Annual observations for Netherlands and HS 300212 where available.

Year	Exports	Year-on-year change	Active destinations
2012	$433.2M	Not reported	123
2013	$466.0M	+7.6%	125
2014	$499.3M	+7.1%	125
2015	$478.9M	-4.1%	154
2016	$504.1M	+5.3%	129
2017	$731.3M	+45.1%	118
2018	$516.5M	-29.4%	123
2019	$609.3M	+18%	114
2020	$785.3M	+28.9%	121
2021	$804.3M	+2.4%	127
2022	$786.8M	-2.2%	144
2023	$1.1B	+38.4%	117
2024	$1.3B	+21.1%	119

Exporter context

Netherlands economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300212.

Netherlands has reported exports of $603.6B and a trade balance of -$42.0B in 2024.

Available structural indicators include 121.9% trade openness, 22% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about Netherlands blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.